Lip cancer treatment with high dose rate brachytherapy

We present 39 patients with lip carcinoma treated with HDR, (needles) with 5–5.5Gy per 8–10 fractions b.i.d. (total dose 40.5–45Gy). Three-year cause-specific survival and local control are 91 and 88% (95% T1–2, 74% T4, p<0.05). Acute and chronic reactions are like LDR cases. We think that HDR re...

Full description

Saved in:
Bibliographic Details
Published inRadiotherapy and oncology Vol. 69; no. 1; pp. 113 - 115
Main Authors Guinot, José-Luis, Arribas, Leoncio, Chust, María Luisa, Mengual, José Luis, Miragall, Enrique García, Carrascosa, María, Escolar, Pedro Pablo, Crispín, Vicente, Guardino, Carmen
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 01.10.2003
Subjects
Adult
Aged
Aged, 80 and over
Brachytherapy
Brachytherapy - adverse effects
Carcinoma, Squamous Cell - radiotherapy
High dose rate
Humans
Lip carcinoma
Lip Neoplasms - radiotherapy
Male
Middle Aged
Radiation Injuries
Radiotherapy Dosage
Brachytherapy
Lip carcinoma
High dose rate
Online AccessGet full text

Cover

More Information
Summary:We present 39 patients with lip carcinoma treated with HDR, (needles) with 5–5.5Gy per 8–10 fractions b.i.d. (total dose 40.5–45Gy). Three-year cause-specific survival and local control are 91 and 88% (95% T1–2, 74% T4, p<0.05). Acute and chronic reactions are like LDR cases. We think that HDR results are equivalent to LDR.
ISSN:0167-8140
1879-0887
DOI:10.1016/S0167-8140(03)00271-8